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The nutritional status of pregnant women is vital for healthy outcomes and is a concern for a large proportion of the world’s
population. The role of the microbiota in pregnancy and nutrition is a promising new area of study with potential health ramifi-
cations. In many African countries, maternal and infant death and morbidity are associated with malnutrition. Here, we assess
the influence of probiotic yogurt containing Lactobacillus rhamnosus GR-1, supplemented with Moringa plant as a source of
micronutrients, on the health and oral, gut, vaginal, and milk microbiotas of 56 pregnant women in Tanzania. In an open-label
study design, 26 subjects received yogurt daily, and 30 were untreated during the last two trimesters and for 1 month after birth.
Samples were analyzed using 16S rRNA gene sequencing, and dietary recalls were recorded. Women initially categorized as
nourished or undernourished consumed similar calories and macronutrients, which may explain why there was no difference in
the microbiota at any body site. Consumption of yogurt increased the relative abundance of Bifidobacterium and decreased En-
terobacteriaceae in the newborn feces but had no effect on the mother’s microbiota at any body site. The microbiota of the oral
cavity and GI tract remained stable over pregnancy, but the vaginal microbiota showed a significant increase in diversity leading
up to and after birth. In summary, daily micronutrient-supplemented probiotic yogurt provides a safe, affordable food for preg-
nant women in rural Tanzania, and the resultant improvement in the gut microbial profile of infants is worthy of further study.
The United Nations estimates that 805 million people arechronically undernourished throughout the world (1). Mal-
nutrition is an additional challenge for pregnant women in many
developing countries, along with access to medical care, exposure
to malaria and HIV, and financial burden. Limited food accessi-
bility, food with poor nutritional value, and cultural traditions
result in deficiencies in essential nutrients. Micronutrients are di-
etary components, often referred to as vitamins and minerals.
Iron, iodine, vitamin A, folate, and zinc are recommended during
pregnancy (2), although unfortunately not all women are recipi-
ents. In many developing countries, including Tanzania, maternal
and newborn death and morbidity are major issues, often propa-
gated by malnourishment (3, 4). Efforts to reduce infant mortality
by supplementation with vitamin A have failed (5). Fermented
foods, including dairy products, have long been part of tradition
in many parts of the African continent. In Tanzania (6), while milk
consumption is high (per capita milk consumption of 39 kg/an-
num), commercial yogurt is not affordable to many, and no
health-promoting probiotic yogurt is sold in traditional retail out-
lets. The establishment of community kitchens in Mwanza in 2004
(7) has provided affordable probiotic yogurt to around 4,000 peo-
ple each day, with some measurable benefits to immunity and gut
health (8, 9).
There is a clear link between the gut microbiota and nutrient
uptake (10), and while the gut microbiota has been reported to be
relatively stable in nonpregnant healthy individuals (11), changes
have been reported in pregnant American and European women,
where Firmicutes, along with Bacteroides dominate. However,
during the first and third trimesters, proteobacteria and actino-
bacteria increase, while richness decreases (12–14). Given the role
of diet on shaping the microbiota (15, 16) and the potential addi-
tional nutritional stresses within impoverished African rural set-
tings, we sought to assess the gut microbiotas of Tanzanian preg-
nant women. Also, since vaginal and oral microbiomes are
suspected to influence pregnancy outcomes (17), and longitudinal
studies seldom have included sampling after birth, we aimed to
better characterize these microbiotas longitudinally.
Few studies have been undertaken on the human milk micro-
biota of African women, even though the transfer of these organ-
isms to infants is critical to development, immunity, risk of disease
later in life, and cognitive function (18, 19). In a Mozambique
study, human milk was found to contain mostly lactic acid bacte-
ria, but proportions were altered by HIV infection (20).
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The probiotic Lactobacillus rhamnosus GR-1 was selected for
use as an intervention in the present study since it has a safe history
of use (8, 9, 21) and was already produced in Mwanza, Tanzania,
as part of the Western Heads East network of microenterprise
community-run kitchens (22). For the purposes of the present
study, the yogurt was further supplemented with dried ground
Moringa oleifera (Moringa), a readily available plant, rich in vita-
min A, proteins, carbohydrate, fiber, minerals, calcium, magne-
sium, phosphorus, potassium, copper, iron, zinc, and manganese
(23) and used commonly in the management of malnutrition
(24). An open-label study was conducted to test a Moringa-sup-
plemented probiotic yogurt and to determine whether it altered
the oral, vaginal, gut, or breast milk microbiotas and had an im-
pact on gestation and health parameters in newborns.
MATERIALS AND METHODS
Study design and participants. The study protocol was approved and
received ethical clearance from both the Medical Research Coordinating
Committee of the National Institute for Medical Research (Mwanza, Tan-
zania), as well as from the Health Sciences Research Ethics Board at West-
ern University (London, Canada). The study was registered with clinical-
trials.gov (NCT02021799). Participants provided written consent, and in
the case where they could not write, a thumbprint was obtained before
sample collection and subsequent analysis.
Women who were attending the antenatal clinic at Nyerere Dispensary
in Buswelu, district of Ilemela, Mwanza Region, Tanzania, were recruited
into the study if they were between the ages of 18 and 40, as well as between
the gestational ages of 12 and 24 weeks. Gestational age was determined by
last menstrual period as identified in the participant’s clinic records. To
confirm, or if last menstrual period was unavailable, approximation of
gestational age was based upon measurement of fundal height. Originally,
participants were further grouped into states of nutritional status (nour-
ished or undernourished) based upon having a mid-upper-arm circum-
ference (MUAC) of 235 mm if undernourished, and deviations from
expected weight for gestational age (25). Since this was a pilot study,
sample size was based on participant availability.
Probiotic yogurt. Subjects were randomly assigned (using a random
number generator) to the intervention group (produced fresh daily yo-
gurt containing 1010 CFU Lactobacillus rhamnosus GR-1 per 250 g unit
confirmed by regular quality control tests, and 4.3 g of dried ground
Moringa oleifera leaves), or control group (no intervention). Administra-
tion of the yogurt amounted to 13% required daily intake of protein (9.95
g), 39% calcium (385 mg), 35% vitamin A (269 retinol activity equiva-
lents), 81% vitamin B2 (1.1 mg), and 4% iron (1.2 mg). The probiotic
group received 250 g of yogurt 6 days a week from the time of recruitment
until exiting the study, which occurred 1 week to 1 month postpartum.
Due to a lack of cold storage available to most participants, yogurt was
delivered daily by a study employee who observed and recorded compli-
ance. Participants in the probiotic group consumed yogurt for an average
of 88 days  31 the standard deviation (SD), while the control group had
no form of intervention.
Assessment and sample collection. At the initial and monthly fol-
low-up visits from recruitment until birth, which occurred between Au-
gust 2012 and April 2013, weight was measured to the nearest 0.1 kg using
an analogue scale, and the MUAC was measured to 1 mm using a tape
measure. A physical examination was also performed at these visits, which
included measurement of blood pressure, heart rate, and general medical
history. Two vaginal swabs were collected at the midpoint of the vagina
using CultureSwab polyester-tipped swabs (BD Biosciences, Mississauga,
Ontario, Canada); one was used for evaluation of bacterial vaginosis (BV)
by Nugent Scoring (26), while the second was used for microbial DNA
extraction. Fecal samples and saliva samples were also collected in sterile
collection containers and frozen at 80C until analysis. A midstream
urine sample was analyzed for urinary tract infection using a multitest
dipstick system (Rapid Response Urine Dipstick; BTNX Urinalysis, Laja
Pharmacy, Mwanza, Tanzania). Hemoglobin levels were determined us-
ing a HemoCue Hb 201 analyser (HemoCue, Ängelholm, Sweden).
Blood samples were collected from all participants at the first, middle,
and final visits in Vacutainer tubes containing potassium EDTA (BD Bio-
sciences, Mississauga, Ontario, Canada). Plasma was separated from the
samples before being frozen at 80°C until analysis. Vitamin A levels were
determined by high-pressure liquid chromatography, while the total
plasma protein levels were determined by a colorimetric biuret assay by
the London Health Sciences Laboratory Services Group (London, On-
tario, Canada).
The first postpartum visits occurred at 3 days after birth, and the final
visit occurred 1 week to 1 month after the first postpartum visit. The same
information and samples were collected as during the follow-up visits;
however, a human milk sample was collected in sterile collection contain-
ers from the mother and stored at 80°C until analysis. Anthropometric
data were collected from the infant, including weight, as measured on an
analogue baby scale to the nearest 0.1 kg, whereas head circumference,
length, and MUAC were measured using a tape measure to the nearest 0.1
cm. In addition, the sex of the infant, the place of birth, and whether the
baby was born vaginally or by caesarean section were recorded. Fecal
samples were collected from the infant’s diaper, and infant saliva samples
were collected using a BBL CultureSwab (BD Diagnostics, Mississauga,
Ontario, Canada) and stored at 80°C until analysis.
Dietary recall analysis. Forty-eight-hour dietary recall interviews
were conducted by a trained study translator at each visit. Information
from these interviews was analyzed for nutritional content and caloric
intake using the ESHA Food Processor SQL (v9.8), which provides access
to an extensive database of comprehensive nutrition information to allow
evaluation of a subject’s diet and fitness. Although this program utilizes
North American food composition tables, nutritional data for local Tan-
zanian foods and recipes were inputted into the software from Tanzanian
food composition tables prepared by Muhimbli University of Health and
Allied Sciences, the Tanzania Food and Nutrition Center, and the Harvard
School of Public Health (27). In addition, when serving sizes per se, or sizes
of specific food items were not clearly stated in the interview, the average
portion quantity, as outlined by the Tanzanian Food Composition Tables,
was used. Nutritional data for Moringa were obtained (M. Broin, unpub-
lished data) and put into ESHA. The average intake of calories, protein,
fat, carbohydrates, saturated fatty acids, monounsaturated fatty acids,
polyunsaturated fatty acids, calcium, vitamin A, folate, and zinc were
calculated over the 48-h period to determine daily consumption. The
same was done for the 48-h dietary recalls collected at the first postpartum
and final visits to obtain a value representing the daily average intake of
the above-listed nutrients postpartum.
Microbial DNA extraction and sequencing. DNA was extracted from
all samples using the PowerSoil-htp 96 Well Soil DNA isolation kit from
MoBio (Carlsbad, CA) according to the manufacturer’s protocol, with
modifications as outlined by the Earth Microbiome Project (version
4_13). Approximately 250 mg of fecal sample, 500 l of saliva and 500 l
of breast milk were used for the extractions. Samples were sequenced by
amplifying the V4 hypervariable region of the 16S rRNA gene using the
bacterial/archaeal primers 515F and 806R according to previously de-
scribed methods (28) and modified for the Illumina MiSeq platform.
Microbial community analysis. Obtained reads were quality filtered
and demultiplexed using the open-source software QIIME (split_librar-
ies_fast.py with default parameters for Illumina sequencing) (29). A total
of 974 samples were sequenced, yielding 15,596,127 sequences total with
an average of 16,012 sequences  11,840 SD per sample. Samples that
generated fewer than 1,000 sequences after quality filtering were dis-
carded. The remaining sequences were then binned into operational tax-
onomic units (OTUs) using closed-reference OTU picking based on 97%
identity using the May 2013 build from the Greengenes reference database
(30). Demultiplexed reads and associated metadata were deposited in the
Bisanz et al.
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Qiita and EBI databases available through study ID 2024 (http://qiita.ucsd
.edu).
Statistical analysis. All statistical analyses were carried out in R using
unpaired Welch’s t tests with Benjamini Hochberg’s false discovery rate
(FDR) method with a q  0.05 cutoff unless otherwise indicated. Analysis
of alpha (Shannon diversity index) and beta diversity (weighted UniFrac
and Bray Curtis) were performed in QIIME. All plotting was carried out in
R with OTUs summarized to genus level and filtered to only include
organisms which composed 1% of the total data set (vaginal heat map
[see Fig. 6C]) or 0.01% (entire data set [see Fig. 3]). For association of
individual genera with yogurt/control treatment in infant fecal samples,
the data set was filtered to include only infant fecal samples, summarized
to the genus level and genera were only kept if they represented a mini-
mum 0.1% of the total reads. Significantly differentially abundant genera
were determined by comparing groups using ALDEx2 (v0.99.2) (31, 32)
by Wilcoxon rank-sum test with FDR correction of centered log-ratio
transformed data using 1,000 Monte-Carlo instances drawn from the
Dirichlet distribution with a minimally informative uniform prior of 0.5.
Taxa that had zero counts in all samples were removed. This approach
accurately estimates the range of technical variation inherent in micro-
biome data sets for all taxa, including those where some samples con-
tained a zero, and some where they contained a positive count (31, 32).
Human milk analysis. The breast milk samples collected at the final
visit for all women in the study were analyzed for fat, protein, and lactose
content. From the calculated lactose amount, the total carbohydrates were
estimated. A total of 12 milk samples were excluded from this analysis due
to the provider being HIV positive. Data were obtained for nine partici-
pants from the control group and six participants from the probiotic
yogurt group. Samples were homogenized for 10 s prior to the removal of
a 500-l aliquot for DNA extraction using a sonicator (VCX 130; Chem-
ical Instruments AB, Sollentuna, Sweden). The remaining sample (ap-
proximately 500 l to 1 ml) was used for nutrient analysis. The lactose
content was measured as described by Fusch et al. (33). Fat was extracted
from the milk using Mojonnier ether extraction and then gravimetrically
analyzed to get the total fat content (34). The protein content of the breast
milk was determined as per the methods of Choi et al. (34). The true
protein content was determined by subtracting the nonprotein nitrogen
from the total nitrogen and multiplying this by 6.25 (35).
RESULTS
Clinical outcomes. The women were enrolled from a 20-km area
around the Nyerere Dispensary on the outskirts of Mwanza. No
verbal or written complaints or side effects were reported from
consumption of the yogurt. Figure 1 shows a CONSORT-compli-
ant study flow chart. Baseline demographic data for the nour-
ished, undernourished, probiotic, and control groups are pre-
sented in Table 1 and showed no differences between groups,
except for weight related metrics between the nourished and un-
dernourished groups. For interpretative purposes, a blood level
for vitamin A of 0.9 mmol/liter equals 25.8 mg/dl just below the
normal range of 30 to 65 g/dl.
Using 48-h dietary recalls, women in both groups who were
initially categorized as nourished or undernourished were found
to have consumed similar calories and macronutrients. In com-
parison to reference dietary intake (RDI) values for Canadian
pregnant women, the Tanzanian women only met the require-
ments for carbohydrates and iron throughout pregnancy; all other
micro- and macronutrients were below 90% of the Canadian RDI,
including folate. However, only three babies (5%) were delivered
preterm, while all other births occurred without adverse events,
and overall, babies examined by the local physician were deemed
to be healthy. It was noted at the study midpoint whereby there
was increased calorie, carbohydrate, thiamine, folate, and zinc in-
take in the probiotic group while blood protein levels were also
higher; however, these were not statistically supported after mul-
tiple testing corrections (Table 2). We noted that the calcium lev-
els in the probiotic group were significantly higher than for all
others (Tables 2 and 3). The fat, carbohydrate, and protein con-
tent of the breast milk and the hemoglobin, blood retinol, or blood
protein concentrations were not altered by yogurt intake, nor was
gestational weight gain or newborn weight at the final visit (Ta-
ble 3).
Microbiome findings. Nutritional status did not correlate
with a difference in microbiota profiles between groups at any
body site both by diversity indices (Fig. 2) or individual taxa (data
not shown; determined by analysis with ALDEx2, which deter-
mines differential abundances for taxa that are robust to technical
replication and that pass a stringent false discovery rate cutoff [31,
32]). It can be noted there was a nonsignificant trend of increased
microbial diversity in undernourished mother’s breast milk and
their infants oral cavities; this was not significant after multiple
testing correction. After initial analysis of the dietary data, blood
protein, and vitamin A (Table 1) and the bacterial communities,
the classification based on nutritional status was rejected, and par-
ticipants were grouped as those receiving Moringa-enriched pro-
biotic supplementation (n 	 23, 14 undernourished) or those
who did not (n 	 24, 7 undernourished).
The mothers’ gut microbiotas were generally dominated by
Prevotella (Fig. 3) but the L. rhamnosus probiotic is not visible
since it comprises a near-undetectable fraction of the fecal micro-
biota. For the oral microbiota, Streptococcus, Prevotella, Fusobac-
terium, Porphyromonas, and other known oral commensals and
pathogens were detected, while the vaginal profiles were predom-
inantly dominated by Lactobacillus (Fig. 3). Clear clustering by
body site was observed in PCoA using the Bray-Curtis dissimilar-
ity measure, with the observation that the infants’ oral and fecal
microbiota seemed most closely related to breast milk (Fig. 4A).
At both 0 to 10 days after birth and 10 to 25 days after birth, there
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Allocated to no intervention (n=30)
- Received no intervention (30)
Allocated to probiotic (n=26)
- Received allocated intervention (26)
Excluded (n=5)
-Obese (n=5)
Randomized (n=56)
Assessed for eligibility (n=61)
 
Follow up at study midpoint (n=23)
-Participant did not return for 
 unknown reasons (n=3)
Analysis midpoint (n=20)
Excluded from analysis (n=3)
-Missed appointment (n=3)
Follow up at study midpoint (n=24)
-Participant did not return for unknown 
 reasons (n=6)
Analysis midpoint (n=22)
Excluded from analysis (n=2)
-Missed appointment (n=2)
Analysis postpartum (n=15)
Excluded from postpartum analysis 
(n=9)
-Age of infant at final visit not between 
 7 and 30 days
Follow up postpartum (n=21)
-Participant relocated for birth (n=3)
Follow up postpartum (n=20)
-Participant relocated for birth (n=2)
-Participant did not give birth by study 
 end date (n=1)
FIG 1 CONSORT study flow diagram.
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was more similarity between the infant’s oral microbiota and their
mother’s breast milk microbiota, than between the infant’s feces
and their mother’s milk (Fig. 4B, P  0.0001, FDR-corrected
Welch’s t test).
To determine the effect of probiotic administration, differ-
ences in the microbiota of each group at each body site were ex-
amined chronologically relative to enrollment using weighted
UniFrac distances (Fig. 5A), and no clear trend was detected com-
paring probiotic to control groups. When the infants of mothers
in the probiotic and control groups are compared by PCoA of
weighted UniFrac distances, weak clustering by treatment group
was observed (Fig. 5B). The OTUs were summarized to genus level
which revealed a 3-fold increase in relative abundance of Bifido-
bacterium and a 16.8-fold decrease in unclassified Enterobacteria-
ceae in the feces of infants whose mothers consumed the yogurt
(P  0.05 [FDR-corrected Wilcoxon rank-sum], Fig. 5C). This
trend was not observed in the breast milk, nor was the primary
macronutrient composition of the milk altered by yogurt intake
(Table 3).
The vaginal microbiota showed a distinct change in beta diver-
sity over gestational time irrespective of treatment group while the
oral and fecal microbiotas did not (Fig. 5A). To analyze this find-
ing further, Shannon diversity index was considered over time
(Fig. 6A) showing a significant increase in alpha diversity in the 10
days after birth to a predominantly BV-type communities as indi-
cated by Nugent score (Fig. 6B, P  0.001 [Welch’s t test]). In the
postnatal period, there was a decrease in Lactobacillus with an
increase in BV-associated organisms such as Prevotella, Veillo-
nella, Poryphromonas, and Megasphaera (Fig. 6C, n 	 32 partici-
pants, P  0.05 [FDR-corrected paired Wilcoxon test]).
DISCUSSION
This study reports the oral, gut, vaginal, and breast milk microb-
iotas of pregnant Tanzanian women and assesses the effects of
consumption of micronutrient-supplemented probiotic yogurt.
None of the mothers or infants died during labor. This finding,
plus the low incidence of preterm labor, no underweight births,
and no serious malnutrition, suggested that this particular rural
population did not typify the Tanzanian situation as a whole,
where the maternal mortality rate is 38.3 times higher than in
Canada and the infant mortality under 1 year of age is 7.6 times
higher (3). Sample size aside, according to the UNICEF statistics,
we would expect two infant deaths in a cohort of this size. There is
an association between an aberrant urogenital microbiota and
preterm labor (36), but the incidence of the latter was low in this
patient group (32%) and similar to that found in London, Canada
(M. Mottola, M. Enos, and G. Reid, unpublished data). Likewise,
periodontal disease with poor oral hygiene has been linked with
preterm labor (37), but the Tanzanian women studied here did
not present with acute periodontal disease as identified during
TABLE 1 Enrollment demographics for probiotic, control, undernourished and nourished groupsa
Parameter
Probiotic vs control Undernourished vs nourished
Probiotic
(n 	 23)
Control
(n 	 24) q value
Undernourished
(n 	 29)
Nourished
(n 	 18) q value
Gestational age (wk) 21  3 20  5 0.915 21  4 21  4 0.976
Age (yr) 23.30  4.42 24.38  5.01 0.915 24.31  5.47 23.11  3.12 0.958
Ht (m) 1.60  0.07 1.62  0.06 0.915 1.61  0.06 1.62  0.07 0.976
Wt (kg) 54.8  5.8 57.5  7.4 0.915 52.6  4.3 62.0  5.9 3.11E–05
% Deviationb 72.71  10.14 96.75  6.58 2.19E–11
MUACc (mm) 261  22 262  22 0.965 256  22 271  19 0.109
Hemoglobin (g/liter) 110.48  13.68 103.38  17.21 0.915 107.34  16.70 106.06  14.75 0.976
HIV (n) 2 3 3 2
Malaria (n) 3 4 4 3
Syphilis (n) 2 2 4 0
Previous pregnancies (n) 2.09  2.07 2.00  1.48 0.965 2.29  1.94 1.67  1.46 0.935
Age of first pregnancy 18.06  9.54 18.88  9.20 0.965 18.19  1.86 19.00  1.97 0.976
Calories (kcal/day) 1,695  752 1,759  781 0.965 1,719  754 1,742  789 0.976
Protein (g/day) 57  23 58  21 0.965 57  21 58  25 0.976
Carbohydrates (g/day) 278  118 276  121 0.965 277  122 277  116 0.997
Fat (g/day) 46  33 52  33 0.915 48  32 51  35 0.976
Vitamin B12 (g/day) 0.69  0.62 0.88  0.81 0.915 0.80  0.76 0.77  0.69 0.976
Thiamine (mg/day) 0.78  0.39 0.90  0.44 0.915 0.86  0.39 0.82  0.46 0.976
Calcium (mg/day) 187  119 236  175 0.915 199  168 233  120 0.976
Vitamin A (RAE/day, median [IQR])d 316 (70–869) 546 (123–1,019) 0.915 261 (98–846) 636 (170–1,018) 0.958
Folate (g/day) 249  212 294  199 0.915 269  206 276  208 0.976
Iron (mg/day) 49  51 40  41 0.915 41  45 50  48 0.976
Zinc (mg/day) 5.4  2.7 5.9  2.4 0.915 5.8  2.5 5.5  2.6 0.976
Blood vitamin A (mmol/liter) 0.90  0.27 1.02  0.43 0.915 1.00  0.31 0.88  0.44 0.958
Blood protein (g/liter) 64.4  8.9 63.5  6.9 0.965 65.8  4.7 60.9  10.7 0.398
a Values represent means  the standard deviations unless indicated otherwise in column 1.
b The percent deviation was calculated based on the participant’s gestational age (calculated from participant recall of the last menstrual period) and height as measured at baseline.
These were used to determine the ideal weight of the participants as outlined by Gueri et al. (25). The weight of the participants measured at baseline was then used to calculate the
percent deviation from the ideal weight.
c MUAC, mid-upper-arm circumference.
d RAE, retinol activity equivalents; IQR, interquartile range.
Bisanz et al.
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their examinations, and their oral microbiotas showed no obvious
abnormality. Thus, with two risk factors for preterm delivery be-
ing absent, it was not surprising to find such a low rate of prema-
ture births. Nevertheless, this is all the more laudable since many
subjects had poor caloric intake. In Tanzania, normally only ca.
50% women have a skilled attendant at birthing according to
UNICEF, and many women have poor access to obstetrical care.
The provision of the latter in our study may have reduced the
preterm labor rate and improved maternal outcome, albeit the
majority of the women delivered at home.
In these settings, access to Moringa and cow’s milk is good,
making it feasible to have the yogurt produced locally. Although
the yogurt was provided here free of charge, the community
kitchen continues to operate and sell the product at a price
(around $0.15) affordable to members of the community. This is
important for sustainability.
We had expected that the daily Moringa yogurt consumption
would have improved nutritional parameters in women present-
ing with a MUAC of 235 mm (undernourished group), since
this food provided a good portion of the required daily intake of
calcium, vitamins, and proteins. However, the baseline levels of
hemoglobin, blood retinol, and protein concentrations suggested
they were not actually overtly malnourished. It is highly probable
that our study suffered from a lack of power and that with an
increased sample size, we may have been able to conclusively dem-
onstrate clinical outcomes as a result of the Moringa-supple-
mented yogurt consumption. A previous study in Mwanza,
Tanzania, using a different combination of micronutrients sup-
plemented in yogurt showed benefits to HIV-positive subjects (9).
Given the previously reported protective effect of probiotic yogurt
supplemented with L. rhamnosus GR-1 and Moringa on increas-
ing blood levels of mercury and arsenic (38), it is important to
note that no difference in hemoglobin was found, suggesting that
probiotic consumption did not negatively affect absorption of
necessary trace elements such as iron.
The mothers’ gut microbiotas were generally dominated by
Prevotella, in agreement with previous reports on children from
Burkina Faso, Malawi, and Tanzania (15, 38, 39) and adults (40).
Potentially, this reflects a high-carbohydrate diet, which was
noted in the dietary recalls.
The vaginal profiles were dominated by Lactobacillus species,
similar to previous findings for American and Brazilian nonpreg-
nant women (41–45) and for pregnant Canadian women (Mot-
tola et al., unpublished). It has long been believed that the vaginal
tract is seeded from the rectum (44), and thus pathogens ascend
TABLE 2 Comparison of probiotic and control groups at the study
midpointa
Parameter
Probiotic
(n 	 20)
Control
(n 	 22) q valued
Gestational age (wk) 32  2 30  4 0.582
Age (yr) 23.5  4.7 24.6  5.1 0.582
Ht (m) 1.59  0.06 1.62  0.06 0.304
Wt (kg) 58.5  5.9 60.1  7.8 0.582
MUACb (mm) 260  23 263  24 0.682
Hemoglobin (g/liter) 102  16 106  24 0.619
Malaria (n) 2 1
Calories (kcal/day) 2,065  656 1,701  486 0.160*
Protein (g/day) 67  12 63  19 0.582
Carbohydrates (g/day) 326  96 264  96 0.160*
Fat (g/day) 60  35 49  19 0.386
Vitamin B12 (g/day) 1.47  0.83 1.41  1.48 0.851
Thiamine (mg/day) 1.00  0.28 0.82  0.19 0.141*
Calcium (mg/day) 488  148 190  92 1.77E–7*
Vitamin A (RAE/day, median
[IQR])c
353 (129–985) 155 (102–268) 0.336
Folate (g/day) 301  160 224  106 0.211*
Iron (mg/day) 44  34 30  22 0.304
Zinc (mg/day) 6.4  2.3 5.1  1.0 0.142*
Blood vitamin A (mol/liter) 0.82  0.25 0.88  0.31 0.607
Blood protein (g/liter) 62.3  8.6 54.8  12.45 0.142*
a Values are expressed as averages and standard deviations unless indicated otherwise in
column 1.
b MUAC, mid-upper-arm circumference.
c RAE, retinol activity equivalents; IQR, interquartile range.
d *, uncorrected P value of 0.05.
TABLE 3 Demographics and birth data for participants in the probiotic
and control groups at the final visita
Parameter
Probiotic
(n 	 9)
Control
(n 	 15) q value
General data
Gestational age at birth (wk) 40  1 40  2 0.976
Age (yr) 24.9  3.4 26.0  5.6 0.787
Ht (m) 1.58  0.05 1.62  0.05 0.598
Wt (kg) 56.2  2.9 55.5  6.7 0.973
MUACb (mm) 267  19 260  23 0.787
Hemoglobin (g/liter) 107  12 111  18 0.787
No. of twin sets 2 0
Infant
Male 5 6
Female 6 9
Age (days) 13  3 12  2 0.787
Wt (kg) 3.5  0.5 3.4  0.4 0.787
Length (cm) 50.7  2.9 48.7  4.0 0.598
Head circumference (cm) 35.9  1.3 35.3  1.2 0.598
MUAC (mm) 11  1 11  1 0.787
Diet
Calories (kcal/day) 1,775  565 2,068  383 0.646
Protein (g/day) 83  38 61  18 0.598
Carbohydrates (g/day) 283  131 363  53 0.598
Fat (g/day) 44  14 49  24 0.787
Vitamin B12 (g/day) 1.36  1.14 0.51  0.66 0.598
Thiamine (mg/day) 0.85  0.25 1.00  0.29 0.598
Calcium (mg/day) 394  139 109  11 	 2 0.003
Vitamin A (RAE/day, median
[IQR])c
190 (107–252) 85 (31–302) 0.899
Folate (g/day) 137  66 157  65 0.787
Iron (mg/day) 67  38 56  46 0.787
Zinc (mg/day) 5.1  2.1 6.4  1.6 0.141
Blood
Blood vitamin A (mol/liter) 1.29  0.34 1.58  0.59 0.598
Blood protein (g/liter) 62.13  9.09 62.73  12.22 0.598
Breast milk
Fat (g/dl) 2.54  0.26 2.80  0.46 0.598
Carbohydrates (g/dl) 5.75  0.18 5.78  0.16 0.787
Protein (g/dl) 1.09  0.06 1.14  0.15 0.787
a Values represent means and standard deviations unless indicated otherwise in
column 1.
b MUAC, mid-upper-arm circumference.
c RAE, retinol activity equivalents; IQR, interquartile range.
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and colonize. One would therefore expect that significantly differ-
ent fecal microbiota patterns would result in differences among
vaginal bacterial profiles. However, this is not the case here or in
other studies, suggesting that the reproductive tract has evolved
receptivity to certain constituents of the gut, mainly lactobacilli,
and an ability to repel others. This niche adaptation warrants fur-
ther investigation.
Rapid development of an aberrant vaginal microbiota imme-
diately after birth is also an interesting finding. A similar discovery
was recently reported by Huang et al. (46); however, that study
was limited in the following ways: (i) it was a cross-sectional de-
sign as opposed to longitudinal in the present study, (ii) postpar-
tum samples were an average of 7 weeks after birth as opposed to
0 to 10 days in the present study, and (iii) the sample size of
postpartum individuals was only 5. Since our study showed sta-
bility in the fecal microbiota from the second trimester until after
birth, this adds to previous findings of the microbiome across
pregnancy in Finish women (12), where the first and third trimes-
ters showed dramatic community shifts. A strength of the present
study is that, unlike previous reports, we examined all three com-
munities (fecal, oral, and vaginal) simultaneously.
The significant increase in the relative abundance of Bifidobac-
terium spp. and a decrease in Enterobacteriaceae in the newborn
gut of babies born to mothers who had received the yogurt is
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noteworthy. All of the mothers breast-fed, so, since glycans in the
milk promote bifidobacterial growth (47), it is not clear why only
the milk from probiotic-treated mothers further increased relative
abundances of these organisms. We found no significant differ-
ences in milk microbiotas and fat, carbohydrate, or protein con-
centrations between the two groups of women. Given the complex
cocktail of bifidogenic glycans and bioactive compounds in breast
milk, it will be necessary to apply further glycomic, proteomic and
FIG 3 Heat map of all samples (n 	 974) at the genus level. Samples were UPGMA (unweighted pair-group method with arithmetic averages) clustered be
weighted UniFrac distances showing strong clustering of samples by body site (as indicated in the lower heat map).
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metabonomic approaches to study the mechanisms through
which micronutrient and probiotic supplementation may affect
breast milk composition and the infant’s microbiota. Perhaps spe-
cific milk oligosaccharides increase following micronutrient/pro-
biotic supplemented yogurt consumption.
The milk clearly supported a diverse range of organisms, which
then colonized the newborn’s intestine and oral cavity. Unlike
North American society, where caesarian delivery and use of in-
fant formula is widespread, the women in this Mwanza commu-
nity almost all deliver vaginally and breast-feed their babies. With
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inflammatory bowel disease and allergies increasing in Canadian
children, potentially linked to environmental factors, including
caesarian section and formula feeding (48, 49), other lessons may
be learned from studying pregnant women in eastern Africa.
In summary, daily ingestion of yogurt supplemented with pro-
biotic L. rhamnosus GR-1 and locally sourced micronutrient-rich
Moringa-supplemented probiotic yogurt provided a safe, inex-
pensive food for pregnant women in rural Tanzania, without ad-
versely changing gut or oral microbial diversity. The baseline nu-
tritional deficiencies illustrated the problems faced by pregnant
women in this region; however, no effects of yogurt supplemen-
tation were observed in the clinical parameters. The resultant im-
provement in the gut microbial profile of infants suggests con-
sumption of this yogurt could be beneficial in this and other
developing world settings but requires further work to understand
the mechanism of action.
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